Aster DM Healthcare Limited has announced a Board of Directors meeting scheduled for April 30, 2026, in compliance with regulatory disclosure requirements. The healthcare company formally notified both stock exchanges about the upcoming board meeting through an official communication dated April 25, 2026.

Meeting Details and Purpose

The board meeting has been convened primarily to review and approve critical financial documents for the fiscal year 2026. The directors will deliberate on the company's audited standalone and consolidated financial results for both the quarter and year ended March 31, 2026.

Regulatory Compliance

The meeting intimation was issued under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring proper disclosure to stakeholders. The company communicated this information to both major Indian stock exchanges where its shares are listed.

Official Communication

Company Secretary and Compliance Officer Hemish Purushottam digitally signed the official notification on April 25, 2026. The communication was addressed to the listing departments of both exchanges, maintaining transparency in corporate governance practices.

Corporate Structure

Aster DM Healthcare Limited operates from multiple locations across India. The company maintains its registered office in Hyderabad, Telangana, while its corporate office is located in Bengaluru, Karnataka. This meeting represents a standard corporate governance practice as the company prepares to disclose its annual financial performance to investors and regulatory authorities.

Aster DM Healthcare has successfully completed its strategic acquisition in the renewable energy sector, purchasing a 26% stake in Oyster Green Hybrid Two Private Limited for a revised consideration of ₹5.80 crore. The healthcare major announced the completion of this acquisition on April 23, 2026, marking a significant milestone in its renewable energy initiative.

Acquisition Completion Details

The company has completed the acquisition through a two-tranche payment structure, with the final tranche completed on April 22, 2026. The investment details are outlined below:

The total consideration was revised from the originally agreed ₹7.00 crore to ₹5.80 crore pursuant to a reduction in the overall project cost. The Group, comprising Aster DM Healthcare and its material subsidiary Malabar Institute of Medical Sciences Limited (MIMS), has completed the acquisition of 26% of the equity share capital of Oyster Green Hybrid Two.

Project Specifications

The acquisition enables Aster DM Healthcare to establish an 18 MWp captive solar power plant in Kerala. Oyster Green Hybrid Two will build, develop, install, commission, operate, manage, and maintain the solar power facility. The company and its material subsidiary MIMS will purchase 100% of the net output electricity generated from this captive solar power plant.

Target Company Profile

Oyster Green Hybrid Two Private Limited was incorporated on January 22, 2024, and is engaged in building, developing, installing, commissioning, operating, and maintaining solar power plants across India. The company's financial position shows:

Strategic Impact

This acquisition represents Aster DM Healthcare's commitment to sustainable energy solutions and operational cost optimization. The 26% stake acquisition complies with statutory requirements under the Electricity Act, which mandates that captive users hold not less than 26% ownership in such projects. The captive solar power plant will provide dedicated clean energy capacity, supporting the company's environmental sustainability goals while ensuring energy security for its healthcare facilities in Kerala.